E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions (Integrated Solutions, Standalone Solutions), Services (Support, Implementation, Training, Network), By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others), By Delivery Mode (Web/Cloud Based, On Premise), By Substances (Controlled Substances, Non-controlled Substances), By Region and Competition, 2020-2030F

Market Overview

The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse. According to Surescripts' 2024 Annual Impact Report, approximately 2.6 billion electronic prescriptions were processed, reflecting substantial utilization in the healthcare ecosystem.

A significant challenge impeding global market expansion is the persistent issue of interoperability, where disparate electronic health record and pharmacy systems often lack seamless communication capabilities. This fragmentation can lead to inefficiencies, data silos, and complications in information exchange across the healthcare continuum.

Key Market Drivers

The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process. According to HealthIT. gov, in 2024, patient access to health information via EHR app-based capabilities grew to 69% in inpatient settings and 64% in outpatient settings. This pervasive integration ensures e-prescribing is an intrinsic component of the digital health ecosystem.

Enhanced patient safety and the reduction of medication errors represent another pivotal market driver. E-prescribing systems mitigate issues from traditional paper prescriptions, such as illegible handwriting and manual transcription errors, which are primary sources of preventable adverse drug events. Digital systems incorporate clinical decision support alerts that flag potential drug-drug interactions, allergies, or incorrect dosages at the point of care, preventing errors proactively. According to the study "Effect of Electronic Prescription System Modifications on Reducing Prescribing Errors in a Military Hospital", published in December 2024 in PMC, electronic prescription modifications led to a significant 49.8% reduction in the overall prescribing error rate. These improvements elevate medication management quality. This market expansion is also evidenced by broader trends; according to Surescripts' 2024 Annual Impact Report, in 2024, 1.34 million prescribers used e-prescribing, marking a 3.9% increase from 2023. These factors highlight digital transformation's essential role in modernizing prescription practices and safeguarding patient well-being.

Download Free Sample Report

Key Market Challenges

A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.

This lack of cohesive data flow directly hampers the growth of the e-prescribing market by complicating information exchange and reducing user satisfaction. According to a HIMSS LinkedIn poll highlighted in a December 2024 HIMSS article, 57% of physicians identified interoperability as their primary obstacle in maximizing health information technology. Such barriers lead to delays in care, redundant testing, and potential medication errors, thereby diminishing the core benefits of e-prescribing and slowing widespread adoption across the healthcare sector.

Key Market Trends

The Global E-Prescribing Market is experiencing transformative shifts driven by technological advancements and evolving healthcare demands. Two prominent trends shaping this landscape are the integration of AI-powered clinical decision support systems and the optimization of real-time pharmacy benefit checks and price transparency.

The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive. Evidence of this growing adoption across the healthcare sector is considerable, with a 2025 AMA survey revealing that 66% of physicians were already utilizing health-AI tools, representing a substantial increase from 38% in 2023. This technological advancement is instrumental in mitigating diagnostic ambiguities, streamlining complex prescribing workflows, and ultimately contributing to superior patient outcomes by facilitating more informed and nuanced decision-making at the point of care.

Another significant trend is the optimization of real-time pharmacy benefit checks (RT-PBC) and the enhancement of prescription price transparency within e-prescribing workflows. This pivotal development empowers prescribers with immediate, patient-specific insights into medication coverage, precise out-of-pocket costs, and readily available therapeutic alternatives directly integrated within their electronic health record systems. This transparent access to financial information allows clinicians to engage proactively in discussions with patients regarding medication affordability, a crucial factor in reducing prescription abandonment rates due to unexpected expenses at the pharmacy. This functionality extends beyond simple cost awareness; it facilitates shared decision-making, where patients can actively participate in selecting the most clinically appropriate and economically viable treatment options. The tangible benefits are evident, as highlighted by Surescripts, a leading health information network, when it reported in its 2024 annual impact report that prescribers leveraging their Real-Time Prescription Benefit tool to identify lower-cost alternatives saved patients an average of US$82 per prescription in 2024. Such advancements further streamline electronic prior authorization processes, effectively reducing administrative burdens for healthcare providers and ensuring patients receive timely access to necessary medications without financial impediments.

Segmental Insights

The Solutions segment is experiencing rapid growth in the Global E-Prescribing Market primarily due to its pivotal role in enhancing patient safety and operational efficiency within healthcare. These solutions are increasingly integrated with Electronic Health Records (EHRs), providing healthcare providers with immediate access to comprehensive patient medication histories, allergy alerts, and potential drug interaction checks, which significantly reduces prescription errors and adverse drug events. Furthermore, regulatory mandates and government initiatives from bodies such as the Centers for Medicare & Medicaid Services (CMS) and the Drug Enforcement Administration (DEA), particularly concerning Electronic Prescribing for Controlled Substances (EPCS), actively drive adoption by standardizing prescription processes and combating fraud. The streamlining of workflows, including automated refill requests and prior authorizations, further contributes to this growth by reducing administrative burden and optimizing provider time.

Regional Insights

North America leads the global e-prescribing market due to a combination of strategic factors within its healthcare landscape. This dominance is primarily driven by robust government initiatives and incentive programs aimed at encouraging the widespread adoption of digital healthcare solutions. Regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS) have implemented mandates, including the requirement for electronic prescribing of controlled substances under Medicare Part D, further accelerating market growth. Additionally, the region benefits from an advanced healthcare infrastructure and a high rate of integration of healthcare IT solutions, including Electronic Health Records systems, which facilitate the seamless implementation and utilization of e-prescribing technologies. This proactive approach to digitization and a strong emphasis on reducing medication errors and enhancing patient safety contribute significantly to North America's leading position.

Recent Developments

• In July 2025, Hackensack Meridian Health partnered with DrFirst to integrate advanced artificial intelligence tools into its existing Epic electronic health record system. This strategic collaboration aimed to enhance the safety and efficiency of medication management workflows. The deployed solutions included clinical-grade AI for data optimization, which substantially improved the automatic mapping of prescription instructions into patient medication histories. Additionally, the partnership provided real-time prescription price transparency, thereby directly contributing to more informed and efficient e-prescribing practices.

• In October 2024, Surescripts announced a collaboration with two prominent healthcare organizations and a pharmacy benefit manager to address prescription prior authorization challenges. This initiative focused on leveraging advanced technology and clinical intelligence to streamline the administrative process for medication approvals. The collaboration aimed to significantly reduce approval times, lower denial rates, and decrease physician abandonment rates, ultimately facilitating quicker patient access to essential medications. This development directly enhanced the efficiency and effectiveness of e-prescribing workflows by simplifying complex administrative requirements.

• In October 2024, Oracle announced its plan to launch a new artificial intelligence-backed electronic health record (EHR) in 2025. This forthcoming EHR system was engineered to integrate AI across the entire clinical workflow, offering features such as voice navigation and search for clinicians. The system also incorporated Oracle's clinical AI agent to assist with drafting clinical documentation, suggesting next steps, and automating coding. This development was intended to significantly improve the efficiency and accuracy of e-prescribing and medication management within healthcare environments.

• In 2024, Epic Systems introduced several generative artificial intelligence (AI) innovations designed to enhance clinical efficiency and personalize patient experiences within its electronic health record platforms. A notable initiative was "Best Care Choices for My Patient," which provided physicians with evidence-based treatment options at the point of care. These AI advancements aimed to streamline tasks such as summarizing patient charts and generating initial drafts of patient communication, thereby improving the overall precision and speed of information access crucial for e-prescribing processes.

Key Market Players

• Oracle Corporation
• Veradigm LLC
• Epic Systems Corporation
• Athenahealth, Inc.
• NextGen Healthcare, Inc.
• McKesson Corporation
• Surescripts, LLC
• Change Healthcare LLC
• Practice Fusion, Inc.
• Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• E-Prescribing Market, By Product:

o   Solutions

o   Services

• E-Prescribing Market, By Specialties:

o   Oncology

o   Sports Medicine

o   Neurology

o   Cardiology

o   Others

• E-Prescribing Market, By Delivery Mode:

o   Web/Cloud Based

o   On Premise

• E-Prescribing Market, By Substances:

o   Controlled Substances

o   Non-controlled Substances

• E-Prescribing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global E-Prescribing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]